Iopromide

Iopromide

Systematic (IUPAC) name
1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-1-N-methylbenzene-1,3-dicarboxamide
Clinical data
AHFS/Drugs.com	International Drug Names
Identifiers
CAS Registry Number	Y
ATC code	V08AB05
PubChem	CID 3736
ChemSpider	3605 N
UNII	712BAC33MZ N
KEGG	D01893 Y
ChEBI	CHEBI:63578 N
ChEMBL	CHEMBL1725 N
Chemical data
Formula	C18H24I3N3O8
Molecular mass	791.11187
SMILES CN(CC(CO)O)C(=O)c1c(c(c(c(c1I)NC(=O)COC)I)C(=O)NCC(CO)O)I
InChI InChI=1S/C18H24I3N3O8/c1-24(4-9(28)6-26)18(31)12-13(19)11(17(30)22-3-8(27)5-25)14(20)16(15(12)21)23-10(29)7-32-2/h8-9,25-28H,3-7H2,1-2H3,(H,22,30)(H,23,29)  N Key:DGAIEPBNLOQYER-UHFFFAOYSA-N  N
N (what is this?)  (verify)

Iopromide is a molecule used as a contrast medium. It is marketed under the name Ultravist which is produced by Bayer Healthcare. It is a low osmolar, non-ionic contrast agent for intravascular use.^[1]

It is commonly used in radiographic studies such as intravenous urograms, brain computer tomography (CT) and CT pulmonary angiograms (CTPAs).

Notes

1. ↑ The entry on Bayer Healthcare's website about Ultravist

External links

• Bayer Schering Pharma global Ultravist Website